miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jia,Han

第一单位： Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China.

作者： Jia,Han ^[1] ; Jie,Li ^[2] ; Kaijie,Tang ^[1] ; Huahua,Zhang ^[3] ; Bo,Guo ^[1] ; Ni,Hou ^[4] ; Chen,Huang ^[5]

作者单位： Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China. ^[1] Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. ^[2] Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China; Medical College, Yan'an University, Yan'an, China. ^[3] Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China. Electronic address: houni@mail.xjtu.edu.cn. ^[4] Department of Cell Biology and Genetics, School of Basic Medical Sciences, Xi'an Jiaotong University Health Science Center, Xi'an, China; Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, China. Electronic address: hchen@mail.xjtu.edu.cn. ^[5]

关键词 5-FU resistance Colon cancer cell mTOR miR-338-3p p53